Navigation Links
The Lanier Law Firm Announces $4.85 Billion National Vioxx Settlement With Merck & Co. Inc.
Date:11/9/2007

Mark Lanier, winner of nation's first Vioxx trial, hails settlement as 'the

right thing to do'

HOUSTON, Nov. 9 /PRNewswire/ -- Attorneys from The Lanier Law Firm are announcing a nationwide settlement agreement with pharmaceutical giant Merck & Co. Inc. (NYSE: MRK) that should resolve at least 85% of the personal injury lawsuits in the U.S. over Vioxx, the company's controversial pain medication.

(Photo: http://www.newscom.com/cgi-bin/prnh/20060623/DAF008)

"This was simply the right thing to do, and we're grateful that the people at Merck recognized that it was the right thing to do," says Houston attorney Mark Lanier, founder of The Lanier Law Firm and lead counsel in the nation's first Vioxx trial. "A lot of lawyers worked hard to get this settlement, which will help thousands of our clients and every other injured Vioxx patient in the United States."

Mr. Lanier has been a national leader in Vioxx litigation since winning a $253 million verdict in the country's first Vioxx lawsuit in August 2005. That case -- decided in favor of the wife of a former marathon runner who died after taking Vioxx for only eight months -- stands as the largest Vioxx verdict in history.

Today's settlement with Whitehouse Station, N.J.-based Merck marks the end of a series of legal battles that began after the company withdrew Vioxx from store shelves in September 2004. Vioxx was pulled from the market after a study revealed that users of the drug were more susceptible to heart attacks and strokes than people using other pain medications.

To interview Mr. Lanier about the Vioxx settlement, please co
'/>"/>

SOURCE The Lanier Law Firm
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Ifbyphone's Virtual Call Center Software Saves DiabetesAmerica Over $240,000 Per Year 2Health News:Ifbyphone's Virtual Call Center Software Saves DiabetesAmerica Over $240,000 Per Year 3Health News:Anesiva Stockholders Approved Merger With Arcion Therapeutics but Merger Remains Contingent on Other Closing Conditions 2Health News:Anesiva Stockholders Approved Merger With Arcion Therapeutics but Merger Remains Contingent on Other Closing Conditions 3Health News:'Sandwich Generation' Avoids Unnecessary Stress While Tending to Aging Senior Parents 2Health News:Frost & Sullivan: E-Healthcare in Western Europe Presents a Significant Market Opportunity for Wireless Technologies 2Health News:Frost & Sullivan: E-Healthcare in Western Europe Presents a Significant Market Opportunity for Wireless Technologies 3Health News:Union Hospital, Hong Kong, Selects First DataBank's Electronic Drug Information in Medication Safety Initiative 2Health News:Union Hospital, Hong Kong, Selects First DataBank's Electronic Drug Information in Medication Safety Initiative 3
Breaking Medicine Technology:FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 2FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 3Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 2Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 3Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 4Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 5Hill-Rom Announces Appointment of James R. Giertz to Board of Directors 2Tepnel Pharmaceutical Services to Offer DNA Genotek 26apos 3Bs Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 15012 1Tepnel Pharmaceutical Services to Offer DNA Genotek 26apos 3Bs Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 15012 2Tepnel Pharmaceutical Services to Offer DNA Genotek 26apos 3Bs Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 15012 3Sentinelle Medical Introduces New Suite of Breast MRI Coils for GE Siemens and Toshiba Scanners 62332 1Sentinelle Medical Introduces New Suite of Breast MRI Coils for GE Siemens and Toshiba Scanners 62332 2Sentinelle Medical Introduces New Suite of Breast MRI Coils for GE Siemens and Toshiba Scanners 62332 3Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 6615 1Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 6615 2Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 6615 3Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 6615 4